Jonathan Wang is the founder of Inmagene Biopharmaceuticals. Inmagene Biopharmaceuticals has raised $40M in total funding. Latest round: Series B.
Jonathan Wang is the founder of Inmagene Biopharmaceuticals, a company focused on immunology-related therapeutic areas. He previously served as Chairman of the Board of Directors and CEO from July 2019 until Inmagene's merger with Ikena Oncology. Wang has over 30 years of healthcare and life sciences experience, including 22 years as a healthcare investor. He was a Partner at OrbiMed and a co-founder of OrbiMed Asia, where he helped manage private equity and venture capital funds totaling US$1.1 billion.
Full founder directory · Investor directory · Company funding database · Fundraising library